Carisma Therapeutics Inc.
Biotechnology
Healthcare
CARM
12.78 M shares
NASDAQ US
traded
02 Jan 2024
listed
no
open
2.92
52 week high
9.49
high
3.06
52 week low
2.37
low
2.67
growth
-21.33 %
previous Close
2.93
P/E ratio
market cap
div yield
0
usd
Jun 2023
qoq
revenue
0.00 %
net incoming
0.00 %
eps
0.00 %
74.61 %
eps surprise
18.33 %
net profit margin
0.00 %
759.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top top